RAC 0.57% $1.75 race oncology ltd

Ann: Bisantrene shows potent anticancer activity in AML models, page-24

  1. 2,645 Posts.
    lightbulb Created with Sketch. 2768
    if that’s the case then was there anything unexpected in these results? I note MYC and mTOR targets where mentioned.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.